Related Experiment Video
Updated: Jan 30, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Two are better than one on progression through MET mechanism for EGFR+ NSCLC patients
Waleed Kian1, Laila C Roisman1, Nir Peled1
1The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
No abstract available in PubMed .
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mechanical Protein Functions
Mechanism of Conjugation
Mechanism of Angiogenesis